150 related articles for article (PubMed ID: 32847935)
1. Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer.
Gerber DE; Putnam WC; Fattah FJ; Kernstine KH; Brekken RA; Pedrosa I; Skelton R; Saltarski JM; Lenkinski RE; Leff RD; Ahn C; Padmanabhan C; Chembukar V; Kasiri S; Kallem RR; Subramaniyan I; Yuan Q; Do QN; Xi Y; Reznik SI; Pelosof L; Faubert B; DeBerardinis RJ; Kim J
Clin Cancer Res; 2020 Nov; 26(22):6017-6027. PubMed ID: 32847935
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer.
Aftab BT; Dobromilskaya I; Liu JO; Rudin CM
Cancer Res; 2011 Nov; 71(21):6764-72. PubMed ID: 21896639
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole induces apoptosis and cell cycle arrest via inhibiting Hedgehog signaling in gastric cancer cells.
Hu Q; Hou YC; Huang J; Fang JY; Xiong H
J Exp Clin Cancer Res; 2017 Apr; 36(1):50. PubMed ID: 28399898
[TBL] [Abstract][Full Text] [Related]
4. Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma.
Kim DJ; Kim J; Spaunhurst K; Montoya J; Khodosh R; Chandra K; Fu T; Gilliam A; Molgo M; Beachy PA; Tang JY
J Clin Oncol; 2014 Mar; 32(8):745-51. PubMed ID: 24493717
[TBL] [Abstract][Full Text] [Related]
5. Anticancer drugs and the regulation of Hedgehog genes GLI1 and PTCH1, a comparative study in nonmelanoma skin cancer cell lines.
Olesen UH; Bojesen S; Gehl J; Haedersdal M
Anticancer Drugs; 2017 Nov; 28(10):1106-1117. PubMed ID: 28799948
[TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection.
Zhou H; Goldman M; Wu J; Woestenborghs R; Hassell AE; Lee P; Baruch A; Pesco-Koplowitz L; Borum J; Wheat LJ
J Clin Pharmacol; 1998 Jul; 38(7):593-602. PubMed ID: 9702843
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the
El-Sheridy NA; El-Moslemany RM; Ramadan AA; Helmy MW; El-Khordagui LK
Drug Deliv; 2021 Dec; 28(1):906-919. PubMed ID: 33960245
[TBL] [Abstract][Full Text] [Related]
8. Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.
Ally MS; Ransohoff K; Sarin K; Atwood SX; Rezaee M; Bailey-Healy I; Kim J; Beachy PA; Chang AL; Oro A; Tang JY; Colevas AD
JAMA Dermatol; 2016 Apr; 152(4):452-6. PubMed ID: 26765315
[TBL] [Abstract][Full Text] [Related]
9. Tumor Progression of Non-Small Cell Lung Cancer Controlled by Albumin and Micellar Nanoparticles of Itraconazole, a Multitarget Angiogenesis Inhibitor.
Zhang L; Liu Z; Yang K; Kong C; Liu C; Chen H; Huang J; Qian F
Mol Pharm; 2017 Dec; 14(12):4705-4713. PubMed ID: 29068216
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas.
Gialmanidis IP; Bravou V; Amanetopoulou SG; Varakis J; Kourea H; Papadaki H
Lung Cancer; 2009 Oct; 66(1):64-74. PubMed ID: 19200615
[TBL] [Abstract][Full Text] [Related]
11. Itraconazole side chain analogues: structure-activity relationship studies for inhibition of endothelial cell proliferation, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, and hedgehog signaling.
Shi W; Nacev BA; Aftab BT; Head S; Rudin CM; Liu JO
J Med Chem; 2011 Oct; 54(20):7363-74. PubMed ID: 21936514
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T.
Muruganandham M; Lupu M; Dyke JP; Matei C; Linn M; Packman K; Kolinsky K; Higgins B; Koutcher JA
Mol Cancer Ther; 2006 Aug; 5(8):1950-7. PubMed ID: 16928815
[TBL] [Abstract][Full Text] [Related]
13. Monitoring Tumor Response to Antivascular Therapy Using Non-Contrast Intravoxel Incoherent Motion Diffusion-Weighted MRI.
Shi C; Liu D; Xiao Z; Zhang D; Liu G; Liu G; Chen H; Luo L
Cancer Res; 2017 Jul; 77(13):3491-3501. PubMed ID: 28487383
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferation of breast cancer cells with itraconazole: Hedgehog pathway inhibition induces apoptosis and autophagic cell death.
Wang X; Wei S; Zhao Y; Shi C; Liu P; Zhang C; Lei Y; Zhang B; Bai B; Huang Y; Zhang H
Cancer Lett; 2017 Jan; 385():128-136. PubMed ID: 27810405
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states.
Abuhelwa AY; Foster DJ; Mudge S; Hayes D; Upton RN
Antimicrob Agents Chemother; 2015 Sep; 59(9):5681-96. PubMed ID: 26149987
[TBL] [Abstract][Full Text] [Related]
16. Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.
Spratlin JL; Cohen RB; Eadens M; Gore L; Camidge DR; Diab S; Leong S; O'Bryant C; Chow LQ; Serkova NJ; Meropol NJ; Lewis NL; Chiorean EG; Fox F; Youssoufian H; Rowinsky EK; Eckhardt SG
J Clin Oncol; 2010 Feb; 28(5):780-7. PubMed ID: 20048182
[TBL] [Abstract][Full Text] [Related]
17. Sensitive and selective quantification of total and free itraconazole and hydroxyitraconazole in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry.
Suzuki Y; Tanaka R; Oyama N; Nonoshita K; Hashinaga K; Umeki K; Sato Y; Hiramatsu K; Kadota JI; Itoh H
Clin Biochem; 2017 Dec; 50(18):1228-1236. PubMed ID: 28928005
[TBL] [Abstract][Full Text] [Related]
18. Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib.
Nikolinakos PG; Altorki N; Yankelevitz D; Tran HT; Yan S; Rajagopalan D; Bordogna W; Ottesen LH; Heymach JV
Cancer Res; 2010 Mar; 70(6):2171-9. PubMed ID: 20215520
[TBL] [Abstract][Full Text] [Related]
19. Phase I dose-escalation trial of the oral investigational Hedgehog signaling pathway inhibitor TAK-441 in patients with advanced solid tumors.
Goldman J; Eckhardt SG; Borad MJ; Curtis KK; Hidalgo M; Calvo E; Ryan DP; Wirth LJ; Parikh A; Partyka J; Faessel H; Gangolli E; Stewart S; Rosen LS; Bowles DW
Clin Cancer Res; 2015 Mar; 21(5):1002-9. PubMed ID: 25501576
[TBL] [Abstract][Full Text] [Related]
20. A simple, sensitive high-performance liquid chromatography -ultraviolet method for the quantification of concentration and steady-state pharmacokinetics of itraconazole and hydroxyitraconazole.
Miura M; Takahashi N; Nara M; Fujishima N; Kagaya H; Kameoka Y; Saitoh H; Tagawa H; Sawada K
Ann Clin Biochem; 2010 Sep; 47(Pt 5):432-9. PubMed ID: 20595406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
